CHIRALITY BIOSCIENCES Trademark

Trademark Overview

On Friday, June 6, 2025, a trademark application was filed for CHIRALITY BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the CHIRALITY BIOSCIENCES trademark a serial number of 99222081. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 6, 2025. This trademark is owned by CMS Biotechnologies, Inc.. The CHIRALITY BIOSCIENCES trademark is filed in the Machinery Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing of enantiopure pharmaceuticals and chemicals for the purpose of reducing human side effects of compounds sold

Device for separating chiral molecules from racemic solutions to create enantiopure chemicals for use in the pharmaceutical, amino acid, small molecule, nutrition, skin and haircare, pesticide, and food preservative industries

Pharmaceutical and chemical laboratories; Pharmaceutical and chemical analysis; Pharmaceutical and chemical research; Development and test of pharmaceutical and chemical production methods; Custom design and development of chemical reagents and biochemical assays; Drug discovery services; Drug discovery services, namely, the separation of conformations of molecules
chirality biosciences

General Information

Serial Number99222081
Word MarkCHIRALITY BIOSCIENCES
Filing DateFriday, June 6, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, June 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesManufacturing of enantiopure pharmaceuticals and chemicals for the purpose of reducing human side effects of compounds sold
Goods and ServicesDevice for separating chiral molecules from racemic solutions to create enantiopure chemicals for use in the pharmaceutical, amino acid, small molecule, nutrition, skin and haircare, pesticide, and food preservative industries
Goods and ServicesPharmaceutical and chemical laboratories; Pharmaceutical and chemical analysis; Pharmaceutical and chemical research; Development and test of pharmaceutical and chemical production methods; Custom design and development of chemical reagents and biochemical assays; Drug discovery services; Drug discovery services, namely, the separation of conformations of molecules

Classification Information

International Class007 - Machines and machine tools; motors and engines (except for land vehicles); machine coupling and transmission components (except for land vehicles); agricultural implements other than hand-operated; incubators for eggs.
US Class Codes013, 019, 021, 023, 024, 031, 034, 035
Class Status Code6 - Active
Class Status DateFriday, June 6, 2025
Primary Code007
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, June 6, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 6, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCMS Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735

Trademark Events

Event DateEvent Description
Friday, June 6, 2025NEW APPLICATION ENTERED
Friday, June 6, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

biosciences chirality pharmaceutical chemical drug molecules development services discovery chemicals enantiopure research